Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age

Journal of Neuroscience

Volumn 27, Issue 49, 2007, Pages 13371-13375

  Horvath, Monika Cs ^a   Kovacs, Gabor G ^b   Kovari, Viktor ^b   Majtenyi, Katalin ^b   Hurd, Yasmin L ^c   Keller, Eva ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

synuclein; opioid receptor; Dopamine transporter; Human; Periaqueductal gray; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN; DIAMORPHINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MESSENGER RNA; MU OPIATE RECEPTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; OPIATE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BRAIN DISEASE; CELL POPULATION; CLINICAL FEATURE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HEROIN DEPENDENCE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIMBIC CORTEX; MESOLIMBIC DOPAMINERGIC SYSTEM; NIGRONEOSTRIATAL SYSTEM; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VENTRAL TEGMENTUM;

AGING; DNA-BINDING PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HEROIN DEPENDENCE; HUMANS; LIMBIC SYSTEM; RECEPTORS, OPIOID; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 37149017723     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2398-07.2007     Document Type: Article

References (33)

1. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preferences paradigm in rats. J Pharmacol Exp Ther 264:489-495.
2. Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ (2002) Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proc Natl Acad Sci USA 99:6382-6385.
3. Berger JR, Arendt G (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 14:214-221.
4. Bonsch D, Reulbach U, Bayerlein K, Hillemacher T, Kornhuber J, Bleich S (2004) Elevated alpha synuclein mRNA levels are associated with craving in patients with alcoholism. Biol Psychiatry 56:984-986.
5. Bonsch D, Greifenberg V, Bayerlein K, Biermann T, Reulbach U, Hillemacher T, Kornhuber J, Bleich S (2005) Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving. Alcohol Clin Exp Res 29:763-765.
6. Chu Y, Kompoliti K, Cochran E, Mufson E, Kordower J (2002) Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol 450:203-214.
7. Cruz-Muros I, Alfonso-Oramas D, Abreu P, Barroso-Chinea P, Rodríguez M, González MC, Hernández TG (2006) Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments. Exp Neurol 204:147-161.
8. el-Agnaf O, Irvine G (2002) Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem Soc Trans 30:559-565.
9. Fagergren P, Smith HR, Daunais JB, Nader MA, Porrino LJ, Hurd YL (2003) Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration. Eur J Neurosci 17:2212-2218.
10. Faure A, Haberland U, Conde F, El Massioui N (2005) Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J Neurosci 25:2771-2780.
11. Ford C, Mark G, Williams J (2006) Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26:2788-2797.
12. Ford CP, Beckstead MJ, Williams JT (2007) Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J Neurophysiol 97:883-891.
13. Glick S, Ramirez R, Livi J, Maisonneuve I (2006) 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats. Eur J Pharmacol 537:94-98.
14. Haber SN, Fudge JL (1997) The primate substantia nigra and VTA: integrative circuitry and function. Crit Rev Neurobiol 11:323-342.
15. Ito R, Dalley JW, Robbins TW, Everitt BJ (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci 22:6247-6253.
16. Jiang C, Wan X, He Y, Pan T, Jankovic J, Le W (2005) Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 191:154-162.
17. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
18. Kim K, Kim C, Hwang D, Seo H, Chung S, Hong S, Lim J, Anderson T, Isacson O (2003) Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 85:622-634.
19. Kish S, Kalasinsky K, Derkach P, Schmunk G, Guttman M, Ang L, Adams V, Furukawa Y, Haycock J (2001) Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology 24:561-567.
20. Maingay M, Romero-Ramos M, Carta M, Kirik D (2006) Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiol Dis 23:522-532.
21. Margolis E, Lock H, Chefer V, Shippenberg T, Hjelmstad G, Fields H (2006) Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci USA 103:2938-2942.
22. Mash D, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin R (2003) Cocaine abusers have an overexpression of α-synuclein in dopamine neurons. J Neurosci 23:2564-2571.
23. Perez R, Waymire J, Lin E, Liu J, Guo F, Zigmond M (2002) A role for α-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090-3099.
24. Perlmann T, Wallén-Mackenzie A (2004) Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res 318:45-52.
25. Pickel V, Chan J, Nirenberg M (2002) Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 45:13-24.
26. Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304-12308.
27. Qin Y, Ouyang Q, Pablo J, Mash DC (2005) Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport 16:1489-1493.
28. Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ (2001) Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76:1565-1572.
29. Simon H, Le Moal M, Stinus L, Calas A (1979) Anatomical relationships between the ventral mesencephalic tegmentum-a 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques. J Neural Transm 44:77-86.
30. Smits S, Ponnio T, Conneely O, Burbach J, Smidt M (2003) Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur J Neurosci 18:1731-1738.
31. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734-1740.
32. Swanson LW (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321-353.
33. Wersinger C, Prou D, Vernier P, Sidhu A (2003) Modulation of dopamine transporter function by a-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 17:2151-2153.